Cardiology and COVID-19: Do we have sufficient information?

Nikita Garg, Brendan McClafferty, Devyani Ramgobin, Reshma Golamari, Rahul Jain, Rohit Jain

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


COVID-19 caused by severe acute respiratory syndrome coronavirus 2, which originated in Wuhan (China), transformed into a worldwide pandemic. The short span associated with the spread of the virus and its varied manifestations presents a steep learning curve for many clinicians on the front-line of treatment. Cardiology is one such affected area. This paper details the signs and symptoms of cardiovascular disease resulting from COVID-19, including its proposed pathophysiology, signs and symptoms, treatments and outcomes under investigation. The consensus is that COVID-19 patients with cardiovascular injury have a shorter duration from symptom onset to deterioration, higher mortality and higher prevalence in older populations. Diagnosis and intervention for patients with underlying cardiovascular comorbidities is critical.

Original languageEnglish (US)
Pages (from-to)705-711
Number of pages7
JournalFuture Cardiology
Issue number4
StatePublished - Jul 2021

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Cardiology and COVID-19: Do we have sufficient information?'. Together they form a unique fingerprint.

Cite this